Liver & Extrahepatic Cell-Selective Nucleic Acid Delivery Based on LNPs Using Novel Ionizable Lipids
2:00 pm - Tuesday 7th April 2026
- Safety and efficacy evaluation of our proprietary ionizable lipids in clinical trials and non-human primate studies
- In vivo immune cells delivery by active and passive targeting strategies using our ionizable lipids
- Ready-to-use LNPs for ex vivo RNA and DNA transfection into human primary T cells
